Sign In
Buy JYNT
$8.27
-0.400 (-4.61%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
Northwest Pipe Company Receives U.S. Patent for Innovative InfraShield® Joint System
04:15pm, Wednesday, 12'th Feb 2025
The Company's revolutionary system enhances steel pressure pipe resilience in differential settlement and seismic applications VANCOUVER, Wash. , Feb. 12, 2025 /PRNewswire/ -- Northwest Pipe Company (
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Kaspi.kz business and prospects, resulting in its stock trading at inflated prices.
TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients' Access to Life-Changing Medicines
08:02am, Wednesday, 12'th Feb 2025
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. CAMBRIDGE, Mass.
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ: KSPI). Such in
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
09:15am, Tuesday, 11'th Feb 2025
New Standalone Company, OraTech Pharmaceuticals Inc., to Focus on Oral Drug Delivery with Strategic Investment and Advanced Manufacturing Capabilities Oramed shareholders to receive the right to a dir
VANCOUVER, BC , Feb. 11, 2025 /PRNewswire/ - Golden Arrow Resources Corporation (TSXV: GRG) (FSE: G6A) (OTCQB: GARWF), (" Golden Arrow " or the "Company") is pleased to announce that the Company an
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Joint Stock Company Kaspi.kz ("Joint Stock Company Kaspi.kz" or the "Company") (NASDAQ: KSPI) of a class action se
Shareholders of Joint Stock Company Kaspi.kz Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - KSPI
04:00am, Tuesday, 11'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present five abstracts featuring new clinical and r
